Search alternatives:
evolveddsssdss. » evolvedddsssdss. (Expand Search)
evolve. » evolved. (Expand Search)
evolves. » evolveds. (Expand Search), evolved. (Expand Search)
Showing 301 - 320 results of 29,812 for search 'form is (((((remote. OR evolveddsssdss.) OR evolve.) OR involves.) OR involved.) OR evolves.)', query time: 0.62s Refine Results
  1. 301

    General Synthesis of Di-μ-oxo Dimanganese Complexes as Functional Models for the Oxygen Evolving Complex of Photosystem II by Hongyu Chen (105612)

    Published 2005
    “…Solutions of the in situ-formed di-μ-oxo dimanganese complexes were characterized by electrospray mass spectrometry, EPR spectroscopy, and UV−visible spectroscopy, and the rates of catalytic oxygen-evolving activity were assayed. …”
  2. 302

    General Synthesis of Di-μ-oxo Dimanganese Complexes as Functional Models for the Oxygen Evolving Complex of Photosystem II by Hongyu Chen (105612)

    Published 2005
    “…Solutions of the in situ-formed di-μ-oxo dimanganese complexes were characterized by electrospray mass spectrometry, EPR spectroscopy, and UV−visible spectroscopy, and the rates of catalytic oxygen-evolving activity were assayed. …”
  3. 303

    General Synthesis of Di-μ-oxo Dimanganese Complexes as Functional Models for the Oxygen Evolving Complex of Photosystem II by Hongyu Chen (105612)

    Published 2005
    “…Solutions of the in situ-formed di-μ-oxo dimanganese complexes were characterized by electrospray mass spectrometry, EPR spectroscopy, and UV−visible spectroscopy, and the rates of catalytic oxygen-evolving activity were assayed. …”
  4. 304

    General Synthesis of Di-μ-oxo Dimanganese Complexes as Functional Models for the Oxygen Evolving Complex of Photosystem II by Hongyu Chen (105612)

    Published 2005
    “…Solutions of the in situ-formed di-μ-oxo dimanganese complexes were characterized by electrospray mass spectrometry, EPR spectroscopy, and UV−visible spectroscopy, and the rates of catalytic oxygen-evolving activity were assayed. …”
  5. 305
  6. 306
  7. 307
  8. 308

    Side-chain moieties from the N-terminal region of Aβ are Involved in an oligomer-stabilizing network of interactions by Kaja Przygońska (5598272)

    Published 2018
    “…Oligomer-defining interactions involving the Aβ peptide N-terminus may be important in production of the neurotoxic forms and thus should not be neglected.…”
  9. 309
  10. 310
  11. 311
  12. 312

    Structural Study of Prolinium/Fumaric Acid Zwitterionic Cocrystals: Focus on Hydrogen-Bonding Pattern Involving Zwitterionic (Ionic) Heterosynthons by Anaëlle Tilborg (1605832)

    Published 2016
    “…Pharmaceutical compounds are mostly developed as solid dosage forms containing a single crystal form. This implies that the selection of a particular crystal state for a given molecule is an important step for further clinical outlooks. …”
  13. 313

    Structural Study of Prolinium/Fumaric Acid Zwitterionic Cocrystals: Focus on Hydrogen-Bonding Pattern Involving Zwitterionic (Ionic) Heterosynthons by Anaëlle Tilborg (1605832)

    Published 2016
    “…Pharmaceutical compounds are mostly developed as solid dosage forms containing a single crystal form. This implies that the selection of a particular crystal state for a given molecule is an important step for further clinical outlooks. …”
  14. 314

    Structural Study of Prolinium/Fumaric Acid Zwitterionic Cocrystals: Focus on Hydrogen-Bonding Pattern Involving Zwitterionic (Ionic) Heterosynthons by Anaëlle Tilborg (1605832)

    Published 2016
    “…Pharmaceutical compounds are mostly developed as solid dosage forms containing a single crystal form. This implies that the selection of a particular crystal state for a given molecule is an important step for further clinical outlooks. …”
  15. 315

    Structural Study of Prolinium/Fumaric Acid Zwitterionic Cocrystals: Focus on Hydrogen-Bonding Pattern Involving Zwitterionic (Ionic) Heterosynthons by Anaëlle Tilborg (1605832)

    Published 2016
    “…Pharmaceutical compounds are mostly developed as solid dosage forms containing a single crystal form. This implies that the selection of a particular crystal state for a given molecule is an important step for further clinical outlooks. …”
  16. 316
  17. 317

    Genes involved in the production of secondary metabolites. by Lumeng Ye (440343)

    Published 2014
    “…The amino acids predicted to be activated by the different A domains by the antiSMASH analysis are indicated without mentioning whether they are in the D- or L- form. B. The ten genes cluster possibly involved in the biosynthesis of a secondary metabolite. …”
  18. 318
  19. 319
  20. 320